report successful normalization of plasma B12 levels in pediatric patients with various cobalamin deficiencies using subcutaneous hydroxocobalamin (OH-Cbl)
These differences do not seem to be secondary to global changes in renal permeability, as urinary protein concentrations (normalized to urine creatinine levels) were unchanged (Figure 4D)
Participants were randomized 1:1:1 to retatrutide 9 mg weekly, retatrutide 12 mg weekly, or placebo, with treatment lasting 68 weeks
Dizziness, fainting, or weakness may be more concerning during vomiting, diarrhea, poor fluid intake, hot weather, or use of diuretics
H., Komlakh, K
However, the mechanisms underlying the PFOS-induced dissipation of mitochondrial membrane potential and whether these mechanisms can be protected by l-Carnitine require further verification